Data_Sheet_5_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_7_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_8_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_11_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_9_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_6_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Table_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Table_2_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data_Sheet_13_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Table_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC حسب Saeid Safiri (3713035)

"…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …"

Data Sheet 1_Negative effects of adverse childhood experiences and absence of positive childhood experiences on healthcare employees: survey findings built on 10 years of trauma-in... حسب Laneita Williamson (20506838)

"…Having 0–2 PCEs relative to 6–7 PCEs was also significantly associated with greater odds of past 2-week compassion fatigue, a lower resilience score, and decreased odds of reported organizational belonging measures. …"

Figure 5 from Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors حسب Eleonora Y. Khlebus (20814571)

"…The <i>x</i>-axis indicates the FC (log₂ scaled), and the <i>y</i>-axis shows the adjusted <i>P</i> value (log₁₀ scaled). Each point represents a different gene; the red/blue color of the points categorize genes with increased/decreased expression in the AGCT-2 subtype, highlighting collagen-related genes as top genes with increased expression in AGCT-2. …"

Data Sheet 1_Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients.pdf حسب Maria Delgado-Ortet (8840702)

"…Changes in volume at week 4 provided better indication of long-term response than the default RECIST assessment at the same time-point. Significant differences were also found between responders and non-responders in the first-order radiomic feature Energy.…"

Supplemental file for Training alters cytokine and soluble receptor responses حسب Jeremy Ducharme (20174820)

"…Following 1-hour of cycling at their respiratory compensation point, untrained men (n=5) exhibited a significant increase in pro-inflammatory cytokines, including IL-6, TNF-α, IL-1β, CCL2, and VEGFA. …"

The number of male–male agonistic interactions in relation to females with maximal swelling. حسب Heungjin Ryu (10747673)

"…<b>(D)</b> Visualization of the interdependency between the number of males and females with maximal swelling on the male aggression rate (significant interaction in LM-2E) shows that when there were a greater number of males in the party, e.g., Mean + 1SD (9.6 males in D), the male aggression rate decreased as the number of females with maximal swelling increased. …"

PbCBP-O is required for efficient midgut traversal. حسب Dominika Kwecka (22170493)

"…<p><b>(A)</b> PbΔCBP-O ookinetes show regular motility. …"

Effects of nano-curcumin on cell migration. حسب Taraneh Givi (22793530)

"…Nano-curcumin in MCF7-S-NC cells significantly decreased cell migration in all time points tested. …"

Table 1_Association between Life’s Crucial 9 and metabolic dysfunction-associated steatotic liver disease: the mediating role of neutrophil-percentage-to-albumin ratio.docx حسب Na Zhu (331131)

"…After adjusting for all confounders, LC9 was significantly and negatively associated with both MASLD (OR = 0.59, 95% CI: 0.54–0.64) and hepatic fibrosis (OR = 0.66, 95% CI: 0.45–0.97), with each 10-point increase in the LC9 score decreasing the prevalence by 41% and 34%, respectively. …"